Drug comparisons
Dapagliflozin vs Linagliptin
Compare Dapagliflozin vs Linagliptin for type 2 diabetes. SGLT2 vs DPP-4: efficacy, heart/kidney benefits, side effects and which may suit you better.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting an add-on oral agent for type 2 diabetes in patients with or at high risk for cardiovascular disease, heart failure or chronic kidney disease.
Bottom line
Dapagliflozin generally offers extra cardiorenal benefits over linagliptin, but neither is universally superior and selection must be personalized by a clinician.
All medication comparisons